Comparison of Complications Between Patients Undergoing Standard Percutaneous Nephrolithotomy With Nephrostomy Tube Placement and Tubeless Percutaneous Nephrolithotomy With Double J Stent Only Placement
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Rabin Medical Center
- Enrollment
- 75
- Locations
- 2
- Primary Endpoint
- Number of Participants with pleural effusion
Study Overview
Brief Summary
Comparison of complications between standard upper pole percutaneous nephrolithotomy (PCNL) with nephrostomy placement and double J stent and PCNL with double J placement only without nephrostomy.
Detailed Description
Measurement of complications in and comparison between two groups of patients undergoing upper pole PCNL. First group consists of patients left with nephrostomy and double J stent and the second group includes patients left with double J stent only without nephrostomy.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients undergoing upper pole percutaneous nephrolithotomy older than 18 years of age and willing to participate
Exclusion Criteria
- •Patients younger than 18 years of age
- •Patients unwilling to participate in the study
- •Patients that nephrostomy tube placement was a prerequisite at the end of the procedure
Arms & Interventions
Nephrostomy tube + double J stent
Standard therapy group with nephrostomy tube and double J stent left at the end of the PCNL
Intervention: nephrostomy tube and double J stent (Device)
Nephrostomy tube + double J stent
Standard therapy group with nephrostomy tube and double J stent left at the end of the PCNL
Intervention: Double J stent without nephrostomy (Device)
Double J stent without nephrostomy
Double J stent only left at the end of the procedure
Intervention: Double J stent without nephrostomy (Device)
Outcomes
Primary Outcomes
Number of Participants with pleural effusion
Time Frame: 30 days
Assessment and comparison of pleural effusion incidence between patients in both groups
Secondary Outcomes
No secondary outcomes reported
Investigators
Hanan Goldberg
MD
Rabin Medical Center